Could patients glean stock tips?: Drug trial participants may be insider trading.

Could patients glean stock tips?: Drug trial participants may be insider trading.
“Patients in clinical trials might be using information about the drug they are taking to trade illegally in pharmaceutical stocks, warns a group of doctors and bioethicists. But they have no idea how prevalent the problem might be.”

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

May 3, 2004

03 May 2004

Financial Snapshot For March 2004: Looking Good

Financial Snapshot For March 2004: Looking Good
“It’s been a rocky first quarter for the biotech stocks � and for the markets in general. Yet, despite investors’ nervousness � about issues as diverse as the terrorist train bombing in Madrid and the departure of Mark McClellan from the FDA � the biotech sector managed to hold its own, and even out-performed the Nasdaq Composite Index.”